Mayne shares are up 80% on takeover news, but there's still money to be made

Resumen detallado
Major shareholders are backing the deal in. The post Mayne shares are up 80% on takeover news, but there's still money to be made appeared first on The Motley Fool Australia.
Mayne Pharma Group Ltd (ASX: MYX) has agreed to a takeover bid from Gedeon Richter Plc, with the offer priced at almost double what the company's shares were changing hands for before the deal was announced.
The drug company's shares closed at $3.21 on Monday, 17 November, and the takeover bid is priced at $6.40.
Mayne Pharma shares shot up to $5.71 in early trade on Tuesday, leaving a decent premium of 12.1% to be made if investors buy in and the deal does eventually go through.
The deal is being unanimously recommended by the Mayne board. Meanwhile the company's three largest shareholders, Funicular Funds with 9.82%, Bruce Mathieson with 6.46% and Trium Capital with 5.85%, have all indicated they will sell their shares into the deal.
Richter is a specialty pharmaceutical company founded in Hungary 125 years ago, with operations in around 50 countries globally.
The deal is fully funded, Mayne said, and will require approval from Mayne shareholders.
Mayne Chair Bruce Robinson said the deal fulfilled the board's purpose to maximise value for shareholders.
The deal will be subject to Foreign Investment Review Board approval and is subject to a positive recommendation from an independent expert.
Mayne was the subject of a $7.40 per share takeover bid by US company Cosette, which later tried to back out of the transaction citing a deterioration in Mayne's financial performance.
Inicio del artículo, extracto de The Motley Fool Australia. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com.au)




